Cargando…

Is There Any Improvement of the Coagulation Imbalance in Sickle Cell Disease after Hematopoietic Stem Cell Transplantation?

Several components of the clotting system are modified towards hypercoagulability in sickle cell disease (SCD). To date, hematopoietic stem cell transplantation (HSCT) is the only validated curative treatment of SCD. Here, we investigated the changes in the hemostatic potential of SCD children who’v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rozen, Laurence, Noubouossie, Denis F., Dedeken, Laurence, Lê, Phu Quoc, Ferster, Alina, Demulder, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912463/ https://www.ncbi.nlm.nih.gov/pubmed/31717804 http://dx.doi.org/10.3390/jcm8111796

Ejemplares similares

Reduction of the Six-Minute Walk Distance in Children with Sickle Cell Disease Is Correlated with Silent Infarct: Results from a Cross-Sectional Evaluation in a Single Center in Belgium
por: Dedeken, Laurence, et al.
Publicado: (2014)

Alteration of humoral, cellular and cytokine immune response to inactivated influenza vaccine in patients with Sickle Cell Disease
por: Nagant, Carole, et al.
Publicado: (2019)

Neonatal Screening for Sickle Cell Disease in Belgium for More than 20 Years: An Experience for Comprehensive Care Improvement
por: Gulbis, Béatrice, et al.
Publicado: (2018)

Hematopoietic Cell Transplantation for Sickle Cell Disease
por: Krishnamurti, Lakshmanan
Publicado: (2021)

Passenger Lymphocyte Syndrome and Autoimmune Hypothyroidism Following Hematopoietic Stem Cell Transplantation
por: Noubouossie, Denis F., et al.
Publicado: (2022)

Usefullness of Heparin Calibrated Anti-Xa Activity to Assess Anticoagulant Activity of Apixaban and Rivaroxaban in Emergency Patients Scheduled for Acute Interventions
por: Riahi, Nada, et al.
Publicado: (2023)

PB2644: NOVEL GLOBAL FIBRINOLYSIS CAPACITY ASSAYS: THE NEXT STEP IN FIBRINOLYSIS SCREENING?
por: Evenepoel, Anton, et al.
Publicado: (2023)

P1635: DETERMINATION OF THE EFFECTIVE CONCENTRATION OF TRANEXAMIC ACID NEUTRALIZING IN AN IN VITRO UROKINASE INDUCED HYPERFIBRINOLYTIC MODEL USING A GLOBAL FIBRINOLYTIC CAPACITY ASSAY
por: Evenepoel, Anton, et al.
Publicado: (2023)

Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Sickle Cell Disease
por: Saraf, Santosh L., et al.
Publicado: (2019)

Serum calprotectin (S100A8/A9): a promising biomarker in diagnosis and follow-up in different subgroups of juvenile idiopathic arthritis
por: La, Céline, et al.
Publicado: (2021)

Global Hemostasis Potential in COVID-19 Positive Patients Performed on St-Genesia Show Hypercoagulable State
por: Buffart, Beverly, et al.
Publicado: (2022)

Hematopoietic Stem Cell Transplantation in Adult Sickle Cell Disease: Problems and Solutions
por: Özdoğu, Hakan, et al.
Publicado: (2015)

Caring for Patients with Sickle Cell Disease during a Pandemic: Continuing to Provide Automated Red Blood Cell Exchange Transfusions in Difficult Times
por: Godby, Richard Curtis, et al.
Publicado: (2020)

Hematopoietic stem cell transplantation in sickle cell disease: patient selection and special considerations
por: Bhatia, Monica, et al.
Publicado: (2015)

Allogeneic hematopoietic stem cell transplantation to cure sickle cell disease: A review
por: Bhalla, Nishka, et al.
Publicado: (2023)

Hematopoietic Stem Cell Transplant for Sickle Cell Disease: PATIENT SELEction and Timing Based on Sickle Cell-Related Multiple Chronic Conditions
por: Jang, Tim, et al.
Publicado: (2021)

Is There Any Reason to Prefer Cord Blood Instead of Adult Donors for Hematopoietic Stem Cell Transplants?
por: Beksac, Meral
Publicado: (2016)

Markers of coagulation activation and acute kidney injury in patients after hematopoietic cell transplantation
por: Hingorani, Sangeeta R, et al.
Publicado: (2015)

Choice of Donor Source and Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Sickle Cell Disease
por: Limerick, Emily, et al.
Publicado: (2019)

Primary caregiver decision-making in hematopoietic cell transplantation and gene therapy for sickle cell disease
por: Sinha, Cynthia B., et al.
Publicado: (2020)

Multimodal phenotyping and correlates of pain following hematopoietic cell transplant in children with sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2023)

Association of Coagulation Activation with Clinical Complications in Sickle Cell Disease
por: Ataga, Kenneth I., et al.
Publicado: (2012)

The hematopoietic saga of clonality in sickle cell disease
por: Stonestrom, Aaron J., et al.
Publicado: (2022)

Awareness and Acceptance of Hematopoietic Stem Cell Transplantation for Sickle Cell Disease in Jazan Province, Saudi Arabia
por: Hurissi, Eman, et al.
Publicado: (2022)

Across the Myeloablative Spectrum: Hematopoietic Cell Transplant Conditioning Regimens for Pediatric Patients with Sickle Cell Disease
por: Limerick, Emily, et al.
Publicado: (2022)

Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease
por: Germino-Watnick, Paula, et al.
Publicado: (2022)

Hematopoietic Stem Cell Transplantation in Thalassemia and Sickle Cell Disease. Unicenter Experience in a Multi-Ethnic Population.
por: Marziali, Marco, et al.
Publicado: (2009)

Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases
por: Arnold, Staci D., et al.
Publicado: (2017)

Long-Term Effects of Allogeneic Hematopoietic Stem Cell Transplantation on Systemic Inflammation in Sickle Cell Disease Patients
por: de Azevedo, Júlia Teixeira Cottas, et al.
Publicado: (2021)

Haploidentical Hematopoietic Stem Cell Transplant Using Post-transplant Cyclophosphamide: A Single-Center Initial Experience in Vietnam
por: Huynh, Man Van, et al.
Publicado: (2021)

Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study
por: Krishnamurti, Lakshmanan, et al.
Publicado: (2022)

Treosulfan-Based Conditioning Regimen in Sibling and Alternative Donor Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease
por: Marzollo, Antonio, et al.
Publicado: (2017)

Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy
por: Kassim, Adetola A., et al.
Publicado: (2022)

P-027: SICKLE CELL DISEASE AND AUTOIMMUNE LIVER DISORDERS: SHOULD HEMATOPOIETIC STEM CELL TRANSPLANTATION BE DISCUSSED EARLY?
por: F., LACAILLE, et al.
Publicado: (2022)

High incidence of suicidal ideation in a series of patients with sickle cell disease after hematopoietic stem cell transplantation
por: Mishkin, Adrienne D., et al.
Publicado: (2022)

P1421: THE EFFECT OF HEMATOPOIETIC STEM CELL TRANSPLANTATION ON CEREBRAL PERFUSION AND OXYGEN METABOLISM IN PATIENTS WITH SICKLE CELL DISEASE
por: Afzali-Hashemi, Liza, et al.
Publicado: (2023)

Mobilizing hematopoietic progenitor cells in donors with sickle cell trait is safe
por: De Santis, Gil Cunha, et al.
Publicado: (2019)

Assessment of Endothelial Injury and Pro-Coagulant Activity Using Circulating Microvesicles in Survivors of Allogeneic Hematopoietic Cell Transplantation
por: Gavriilaki, Eleni, et al.
Publicado: (2020)

Effective sickle hemoglobin reduction by automated red cell exchange using Spectra Optia in three Emirati patients with sickle cell disease before allogeneic hematopoietic stem cell transplantation
por: Choi, Seung Jun, et al.
Publicado: (2018)

A Child as a Donor for Hematopoietic Stem Cell Transplantation: Bioethical Justification—A Case Study on Sickle Cell Disease
por: Pereira, Andrea Z., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7iaqje08i677j3flnm598sl2as